Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Kaempferia parviflora ethanol extract improves self-assessed sexual health in men: a pilot study.

Stein RA, Schmid K, Bolivar J, Swick AG, Joyal SV, Hirsh SP.

J Integr Med. 2018 Jul;16(4):249-254. doi: 10.1016/j.joim.2018.05.005. Epub 2018 May 26.

PMID:
29880257
2.

Identity Crisis - Rigor and Reproducibility in Human Cell Lines.

Eckers JC, Swick AD, Kimple RJ.

Radiat Res. 2018 Jun;189(6):551-552. doi: 10.1667/RR15086.1. Epub 2018 Apr 13. No abstract available.

PMID:
29652622
3.

Measurement of Lipoprotein-Associated Phospholipase A2 by Use of 3 Different Methods: Exploration of Discordance between ELISA and Activity Assays.

Topbas C, Swick A, Razavi M, Anderson NL, Pearson TW, Bystrom C.

Clin Chem. 2018 Apr;64(4):697-704. doi: 10.1373/clinchem.2017.279752. Epub 2018 Jan 10.

PMID:
29321128
4.

Towards natural mimetics of metformin and rapamycin.

Aliper A, Jellen L, Cortese F, Artemov A, Karpinsky-Semper D, Moskalev A, Swick AG, Zhavoronkov A.

Aging (Albany NY). 2017 Nov 15;9(11):2245-2268. doi: 10.18632/aging.101319.

5.

Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition.

Prabakaran PJ, Javaid AM, Swick AD, Werner LR, Nickel KP, Sampene E, Hu R, Ong IM, Bruce JY, Hartig GK, Wieland AM, Canon J, Harari PM, Kimple RJ.

Clin Cancer Res. 2017 Oct 15;23(20):6044-6053. doi: 10.1158/1078-0432.CCR-17-0969. Epub 2017 Jun 28.

PMID:
28659312
6.

Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.

Swick AD, Prabakaran PJ, Miller MC, Javaid AM, Fisher MM, Sampene E, Ong IM, Hu R, Iida M, Nickel KP, Bruce JY, Wheeler DL, Kimple RJ.

Mol Cancer Ther. 2017 Jul;16(7):1257-1268. doi: 10.1158/1535-7163.MCT-17-0115. Epub 2017 Apr 26.

7.

Defining the boundaries and expanding the utility of head and neck cancer patient derived xenografts.

Swick AD, Stein AP, McCulloch TM, Hartig GK, Ong IM, Sampene E, Prabakaran PJ, Liu CZ, Kimple RJ.

Oral Oncol. 2017 Jan;64:65-72. doi: 10.1016/j.oraloncology.2016.11.017. Epub 2016 Dec 8.

8.

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.

Aliper A, Belikov AV, Garazha A, Jellen L, Artemov A, Suntsova M, Ivanova A, Venkova L, Borisov N, Buzdin A, Mamoshina P, Putin E, Swick AG, Moskalev A, Zhavoronkov A.

Aging (Albany NY). 2016 Sep 24;8(9):2127-2152. doi: 10.18632/aging.101047.

9.

Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.

Iida M, Bahrar H, Brand TM, Pearson HE, Coan JP, Orbuch RA, Flanigan BG, Swick AD, Prabakaran PJ, Lantto J, Horak ID, Kragh M, Salgia R, Kimple RJ, Wheeler DL.

Mol Cancer Ther. 2016 Sep;15(9):2175-86. doi: 10.1158/1535-7163.MCT-16-0012. Epub 2016 Jul 15.

10.

Rapid induction and persistence of paracrine-induced cellular antiviral states arrest viral infection spread in A549 cells.

Voigt EA, Swick A, Yin J.

Virology. 2016 Sep;496:59-66. doi: 10.1016/j.virol.2016.05.019. Epub 2016 May 30.

11.

Tools for Single-Cell Kinetic Analysis of Virus-Host Interactions.

Warrick JW, Timm A, Swick A, Yin J.

PLoS One. 2016 Jan 11;11(1):e0145081. doi: 10.1371/journal.pone.0145081. eCollection 2016.

12.

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models.

Francis DM, Huang S, Armstrong EA, Werner LR, Hullett C, Li C, Morris ZS, Swick AD, Kragh M, Lantto J, Kimple RJ, Harari PM.

Clin Cancer Res. 2016 Feb 1;22(3):633-43. doi: 10.1158/1078-0432.CCR-15-1664. Epub 2015 Sep 29.

13.

Modulation of therapeutic sensitivity by human papillomavirus.

Swick AD, Chatterjee A, De Costa AM, Kimple RJ.

Radiother Oncol. 2015 Sep;116(3):342-5. doi: 10.1016/j.radonc.2015.09.002. Epub 2015 Sep 10. Review.

14.

Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Stein AP, Saha S, Kraninger JL, Swick AD, Yu M, Lambert PF, Kimple RJ.

Cancer J. 2015 May-Jun;21(3):138-46. doi: 10.1097/PPO.0000000000000115. Review.

15.

Genome rearrangement affects RNA virus adaptability on prostate cancer cells.

Pesko K, Voigt EA, Swick A, Morley VJ, Timm C, Yin J, Turner PE.

Front Genet. 2015 Apr 1;6:121. doi: 10.3389/fgene.2015.00121. eCollection 2015.

16.

Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies.

Stein AP, Swick AD, Smith MA, Blitzer GC, Yang RZ, Saha S, Harari PM, Lambert PF, Liu CZ, Kimple RJ.

Cancer Med. 2015 May;4(5):699-712. doi: 10.1002/cam4.387. Epub 2015 Jan 26.

17.

Wetting the whistle: neurotropic factor improves salivary function.

Swick A, Kimple RJ.

J Clin Invest. 2014 Aug;124(8):3282-4. doi: 10.1172/JCI77194. Epub 2014 Jul 18.

18.

Supporting a healthy microbiome and patient outcomes with probiotics.

Contractor N, Swick AG, Montalto MB, Troup JP.

Glob Adv Health Med. 2014 May;3(3):3. doi: 10.7453/gahmj.2014.033. No abstract available.

19.

Visualizing infection spread: dual-color fluorescent reporting of virus-host interactions.

Swick A, Baltes A, Yin J.

Biotechnol Bioeng. 2014 Jun;111(6):1200-9. doi: 10.1002/bit.25170. Epub 2013 Dec 28.

20.

Interface between pharmacotherapy and genes in human obesity.

O'Connor A, Swick AG.

Hum Hered. 2013;75(2-4):116-26. doi: 10.1159/000349975. Epub 2013 Sep 27. Review.

21.

Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta.

Meganck JA, Begun DL, McElderry JD, Swick A, Kozloff KM, Goldstein SA, Morris MD, Marini JC, Caird MS.

Bone. 2013 Sep;56(1):204-12. doi: 10.1016/j.bone.2013.06.003. Epub 2013 Jun 14.

22.

Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass.

Swick AG, Orena S, O'Connor A.

Metabolism. 2013 Aug;62(8):1070-3. doi: 10.1016/j.metabol.2013.02.012. Epub 2013 Apr 8.

PMID:
23578923
23.

Discovery of new piperidine amide triazolobenzodiazepinones as intestinal-selective CCK1 receptor agonists.

Cameron KO, Beretta EE, Chen Y, Chu-Moyer M, Fernando D, Gao H, Kohrt J, Lavergne S, Jardine Pda S, Guzman-Perez A, Hoth C, Perry DA, Hadcock JR, Gautreau D, Makowski M, Perez S, Polivkova J, Rogers L, Scott DO, Swick AG, Thiede L, Trebino CE, Trilles RV, Wilmowski J, Zhang Y.

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2943-7. doi: 10.1016/j.bmcl.2012.02.049. Epub 2012 Feb 23.

PMID:
22424974
24.

Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.

Robinson RP, Bartlett JA, Bertinato P, Bessire AJ, Cosgrove J, Foley PM, Manion TB, Minich ML, Ramos B, Reese MR, Schmahai TJ, Swick AG, Tess DA, Vaz A, Wolford A.

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4150-4. doi: 10.1016/j.bmcl.2011.05.099. Epub 2011 Jun 2.

PMID:
21684740
25.

Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Lam M, Hsia AH, Liu Y, Guo M, Swick AR, Berlin JC, McCormick TS, Kenney ME, Oleinick NL, Cooper KD, Baron ED.

Clin Exp Dermatol. 2011 Aug;36(6):645-51. doi: 10.1111/j.1365-2230.2010.03989.x. Epub 2011 May 30. Review.

26.

Leptin potentiates the anti-obesity effects of rimonabant.

Boustany-Kari CM, Jackson VM, Gibbons CP, Swick AG.

Eur J Pharmacol. 2011 May 11;658(2-3):270-6. doi: 10.1016/j.ejphar.2011.02.021. Epub 2011 Mar 1.

PMID:
21371466
27.

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity.

Elliott RL, Cameron KO, Chin JE, Bartlett JA, Beretta EE, Chen Y, Jardine Pda S, Dubins JS, Gillaspy ML, Hargrove DM, Kalgutkar AS, LaFlamme JA, Lame ME, Martin KA, Maurer TS, Nardone NA, Oliver RM, Scott DO, Sun D, Swick AG, Trebino CE, Zhang Y.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6797-801. doi: 10.1016/j.bmcl.2010.08.115. Epub 2010 Sep 28.

PMID:
20851601
28.

Identification and characterization of a leptin-responsive neuroblastoma cell line.

Wang R, Swick AG.

Biochem Biophys Res Commun. 2009 Feb 20;379(4):835-9. doi: 10.1016/j.bbrc.2008.12.157. Epub 2009 Jan 4.

PMID:
19126399
29.

Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling.

Somani AK, Swick AR, Cooper KD, McCormick TS.

Arch Dermatol. 2008 Oct;144(10):1341-9. doi: 10.1001/archderm.144.10.1341.

30.

Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin.

Toichi E, Lu KQ, Swick AR, McCormick TS, Cooper KD.

J Invest Dermatol. 2008 Nov;128(11):2705-15. doi: 10.1038/jid.2008.137. Epub 2008 May 29.

31.

Determination of in vivo dose response and allergen-specific T cells in subjects contact-sensitized to squaric acid dibutyl ester.

Camouse MM, Swick AR, Ryan CA, Hulette B, Gerberick F, Tinkle SS, Nedorost ST, Cooper KD, Stevens SR, Baron ED.

Dermatitis. 2008 Mar-Apr;19(2):95-9.

PMID:
18413111
32.

Age differences in inflammatory and hypermetabolic postburn responses.

Jeschke MG, Norbury WB, Finnerty CC, Mlcak RP, Kulp GA, Branski LK, Gauglitz GG, Herndon B, Swick A, Herndon DN.

Pediatrics. 2008 Mar;121(3):497-507. doi: 10.1542/peds.2007-1363.

PMID:
18310198
33.

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.

Siuciak JA, Chapin DS, McCarthy SA, Guanowsky V, Brown J, Chiang P, Marala R, Patterson T, Seymour PA, Swick A, Iredale PA.

Neuropharmacology. 2007 Feb;52(2):279-90. Epub 2006 Sep 1.

PMID:
16949622
34.

The SloR/Dlg metalloregulator modulates Streptococcus mutans virulence gene expression.

Rolerson E, Swick A, Newlon L, Palmer C, Pan Y, Keeshan B, Spatafora G.

J Bacteriol. 2006 Jul;188(14):5033-44. Erratum in: J Bacteriol. 2006 Sep;188(18):6718.

35.

Food intake in rhesus monkeys following central administration of orexins.

Ramsey JJ, Kemnitz JW, Newton W, Hagopian K, Patterson TA, Swick AG.

Regul Pept. 2005 Jan 15;124(1-3):209-14.

PMID:
15544861
36.

Leptin acts peripherally to limit meal-induced increases in plasma insulin concentrations in mice: a brief communication.

Mistry AM, Swick AG, Romsos DR.

Exp Biol Med (Maywood). 2004 Nov;229(10):1033-7.

PMID:
15522839
37.

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics.

Dow RL, Schneider SR, Paight ES, Hank RF, Chiang P, Cornelius P, Lee E, Newsome WP, Swick AG, Spitzer J, Hargrove DM, Patterson TA, Pandit J, Chrunyk BA, LeMotte PK, Danley DE, Rosner MH, Ammirati MJ, Simons SP, Schulte GK, Tate BF, DaSilva-Jardine P.

Bioorg Med Chem Lett. 2003 Feb 10;13(3):379-82.

PMID:
12565933
38.
39.

Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists.

Morgan BP, Swick AG, Hargrove DM, LaFlamme JA, Moynihan MS, Carroll RS, Martin KA, Lee E, Decosta D, Bordner J.

J Med Chem. 2002 Jun 6;45(12):2417-24.

PMID:
12036351
40.

Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status.

Kanaley JA, Sames C, Swisher L, Swick AG, Ploutz-Snyder LL, Steppan CM, Sagendorf KS, Feiglin D, Jaynes EB, Meyer RA, Weinstock RS.

Metabolism. 2001 Aug;50(8):976-82.

PMID:
11474488
41.
42.

Leptin is a potent stimulator of bone growth in ob/ob mice.

Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG.

Regul Pept. 2000 Aug 25;92(1-3):73-8.

PMID:
11024568
43.

Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice.

Mistry AM, Swick A, Romsos DR.

Am J Physiol. 1999 Sep;277(3 Pt 2):R742-7.

PMID:
10484491
44.

Ethanol inhibits L1-mediated neurite outgrowth in postnatal rat cerebellar granule cells.

Bearer CF, Swick AR, O'Riordan MA, Cheng G.

J Biol Chem. 1999 May 7;274(19):13264-70.

45.

Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure.

Bearer CF, Lee S, Salvator AE, Minnes S, Swick A, Yamashita T, Singer LT.

Alcohol Clin Exp Res. 1999 Mar;23(3):487-93.

PMID:
10195823
46.

A role for leptin in brain development.

Steppan CM, Swick AG.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):600-2.

PMID:
10080944
47.

Different central and peripheral responses to leptin in rhesus monkeys: brain transport may be limited.

Ramsey JJ, Kemnitz JW, Colman RJ, Cunningham D, Swick AG.

J Clin Endocrinol Metab. 1998 Sep;83(9):3230-5.

PMID:
9745433
48.
49.

Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter.

Jensen DE, Black AR, Swick AG, Azizkhan JC.

J Cell Biochem. 1997 Oct 1;67(1):24-31.

PMID:
9328836
50.

Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice.

Mistry AM, Swick AG, Romsos DR.

J Nutr. 1997 Oct;127(10):2065-72.

PMID:
9311966

Supplemental Content

Support Center